Peterson Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$302K Buy
328
+62
+23% +$62.9K 0.17% 38
2025
Q4
$286K Buy
+266
New +$254K 0.21% 35
2025
Q3
Sell
-4,047
Closed -$3.15M 41
2025
Q2
$3.15M Sell
4,047
-110
-3% -$85.5K 1.87% 23
2025
Q1
$3.43M Sell
4,157
-794
-16% -$661K 2.31% 16
2024
Q4
$3.82M Buy
4,951
+1,065
+27% +$882K 2.27% 17
2024
Q3
$3.44M Sell
3,886
-801
-17% -$720K 2.2% 17
2024
Q2
$4.24M Buy
4,687
+1,198
+34% +$958K 2.62% 14
2024
Q1
$2.71M Buy
3,489
+700
+25% +$498K 1.96% 18
2023
Q4
$1.63M Sell
2,789
-285
-9% -$166K 1.46% 22
2023
Q3
$1.65M Sell
3,074
-1,062
-26% -$547K 1.36% 21
2023
Q2
$1.94M Buy
4,136
+29
+0.7% +$12.2K 1.54% 16
2023
Q1
$1.41M Buy
4,107
+1,115
+37% +$376K 1.35% 21
2022
Q4
$1.09M Sell
2,992
-1,327
-31% -$470K 1.12% 26
2022
Q3
$1.4M Buy
4,319
+127
+3% +$40.2K 1.3% 23
2022
Q2
$1.36M Buy
4,192
+28
+0.7% +$8.4K 1.76% 19
2022
Q1
$1.19M Buy
+4,164
New +$1.07M 0.8% 38

Other funds holding LLY

Peterson Wealth Management's LLY Position: Q1 2026 in Review

Peterson Wealth Management increased its Eli Lilly (LLY) stake by 23% in Q1 2026, buying an estimated $62.9K and bringing the position to 328 shares worth $302K. The position accounts for 0.17% of the portfolio, ranked #38.

Peterson Wealth Management first reported a position in LLY in Q1 2022 and has held it in 16 quarters since. The position peaked at $4.24M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Peterson Wealth Management held 328 shares of Eli Lilly worth $302K as of Q1 2026.
  • Peterson Wealth Management bought 62 Eli Lilly shares in Q1 2026, an estimated $62.9K.
  • Eli Lilly made up 0.17% of Peterson Wealth Management's portfolio in Q1 2026, its #38 holding.
  • Peterson Wealth Management first reported a position in Eli Lilly in Q1 2022 and has held it in 16 quarters since.
  • Peterson Wealth Management's Eli Lilly position peaked at $4.24M in Q2 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Peterson Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.